Market Cap 303.99M
Revenue (ttm) 0.00
Net Income (ttm) -45.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 900,800
Avg Vol 1,737,102
Day's Range N/A - N/A
Shares Out 30.68M
Stochastic %K 79%
Beta 3.35
Analysts Strong Sell
Price Target $27.57

Company Profile

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 561 8600
Address:
155 Bovet Road, Suite 303, San Mateo, United States
LakeAccess
LakeAccess Jul. 12 at 1:41 AM
0 · Reply
chwast94
chwast94 Jul. 11 at 8:00 PM
$SGMT moment of truth is coming next week. Stock is ready to make a big jump. Hopefully in the right direction. Hold on to your butts
1 · Reply
SouthHaus
SouthHaus Jul. 11 at 7:29 PM
$SGMT I haven’t had this much fun since my cervical discectomy and fusion procedure!
0 · Reply
idousky
idousky Jul. 11 at 7:20 PM
$SGMT I doubled what I put in and now it’s time to sell in my opinion. It’s been a great run
0 · Reply
EdwardTeach
EdwardTeach Jul. 11 at 6:40 PM
$LSTA $SLNO $VKTX $BWAY $SGMT There's no reason why this isn't over $4...glta
0 · Reply
Stocks4thought
Stocks4thought Jul. 11 at 4:45 PM
$LSTA ASCEND trial data for Lisata Therapeutics’ certepetide in metastatic pancreatic cancer (mPDAC) is clinically meaningful and scientifically promising Cohort B (newest update – June 2025) 6-month progression-free survival (6MPFS): Certepetide arm: 60.8% Placebo arm: 25% +35.8% absolute improvement — this is very strong for mPDAC. Median PFS: Certepetide: 7.5 months Placebo: 4.7 months ~60% relative improvement — clinically meaningful. Objective Response Rate (ORR): Certepetide: 45.2% Placebo: 19% More than doubling the response rate, which is rare in pancreatic cancer. ot $SLNO $VKTX $BWAY $SGMT etc
3 · Reply
Norny44
Norny44 Jul. 11 at 10:26 AM
$SGMT interested to see if this continues to climb today?. Expecting a drop back with lower volume but who knows??. It's holding well above £9 now. Still waiting on the break out!!!!
0 · Reply
chwast94
chwast94 Jul. 10 at 8:23 PM
$SGMT not to mention that their short position is not fully hedged. It’s likely the call options are a partial hedge, but there’s not enough calls out there to close that entire position. Just a matter of time before they flip their position, buy a shit ton of calls, and start closing to profit from the upside
0 · Reply
chwast94
chwast94 Jul. 10 at 8:18 PM
$SGMT another reminder that they did not close their short positions! All we’ve seen is organic buy pressure on the acne news. To close 15% short position without willing sellers, the stock might rip 2-5x. No ceiling if no sellers. And everyday we’re getting closer to generating revenue or buyout
0 · Reply
AnyaGirl
AnyaGirl Jul. 10 at 4:05 PM
$SGMT hoping it breaks 10$ and flies up to 25 :)
0 · Reply
Latest News on SGMT
Sagimet Biosciences' Denifanstat Should Be Worth More Today

Mar 7, 2025, 4:27 PM EST - 4 months ago

Sagimet Biosciences' Denifanstat Should Be Worth More Today


Sagimet: More Than Just A MASH Drug Development Biotech

Nov 14, 2024, 3:56 PM EST - 8 months ago

Sagimet: More Than Just A MASH Drug Development Biotech


Sagimet Biosciences Announces Leadership Changes

Jul 20, 2023, 4:05 PM EDT - 2 years ago

Sagimet Biosciences Announces Leadership Changes


IPO Update: Sagimet Biosciences Pushes Forward On IPO Plan

Jul 11, 2023, 5:41 PM EDT - 2 years ago

IPO Update: Sagimet Biosciences Pushes Forward On IPO Plan


LakeAccess
LakeAccess Jul. 12 at 1:41 AM
0 · Reply
chwast94
chwast94 Jul. 11 at 8:00 PM
$SGMT moment of truth is coming next week. Stock is ready to make a big jump. Hopefully in the right direction. Hold on to your butts
1 · Reply
SouthHaus
SouthHaus Jul. 11 at 7:29 PM
$SGMT I haven’t had this much fun since my cervical discectomy and fusion procedure!
0 · Reply
idousky
idousky Jul. 11 at 7:20 PM
$SGMT I doubled what I put in and now it’s time to sell in my opinion. It’s been a great run
0 · Reply
EdwardTeach
EdwardTeach Jul. 11 at 6:40 PM
$LSTA $SLNO $VKTX $BWAY $SGMT There's no reason why this isn't over $4...glta
0 · Reply
Stocks4thought
Stocks4thought Jul. 11 at 4:45 PM
$LSTA ASCEND trial data for Lisata Therapeutics’ certepetide in metastatic pancreatic cancer (mPDAC) is clinically meaningful and scientifically promising Cohort B (newest update – June 2025) 6-month progression-free survival (6MPFS): Certepetide arm: 60.8% Placebo arm: 25% +35.8% absolute improvement — this is very strong for mPDAC. Median PFS: Certepetide: 7.5 months Placebo: 4.7 months ~60% relative improvement — clinically meaningful. Objective Response Rate (ORR): Certepetide: 45.2% Placebo: 19% More than doubling the response rate, which is rare in pancreatic cancer. ot $SLNO $VKTX $BWAY $SGMT etc
3 · Reply
Norny44
Norny44 Jul. 11 at 10:26 AM
$SGMT interested to see if this continues to climb today?. Expecting a drop back with lower volume but who knows??. It's holding well above £9 now. Still waiting on the break out!!!!
0 · Reply
chwast94
chwast94 Jul. 10 at 8:23 PM
$SGMT not to mention that their short position is not fully hedged. It’s likely the call options are a partial hedge, but there’s not enough calls out there to close that entire position. Just a matter of time before they flip their position, buy a shit ton of calls, and start closing to profit from the upside
0 · Reply
chwast94
chwast94 Jul. 10 at 8:18 PM
$SGMT another reminder that they did not close their short positions! All we’ve seen is organic buy pressure on the acne news. To close 15% short position without willing sellers, the stock might rip 2-5x. No ceiling if no sellers. And everyday we’re getting closer to generating revenue or buyout
0 · Reply
AnyaGirl
AnyaGirl Jul. 10 at 4:05 PM
$SGMT hoping it breaks 10$ and flies up to 25 :)
0 · Reply
norbertm
norbertm Jul. 10 at 3:34 PM
$SGMT I’m only watching from the sidelines now, but this stock is just a beauty, keeps coming back strong after every backward move from 9 or 10; this is the third or fourth time in the few weeks I have been observing (traded it once from 7 to 10). GL to the longs, hope it blasts off soon past 10.
2 · Reply
Norny44
Norny44 Jul. 10 at 1:15 PM
$SGMT Break $10 again today ????
0 · Reply
Casperblaster
Casperblaster Jul. 9 at 7:43 PM
$SGMT lets hear some targets. Im looking for a break above $10. Already covered my calls with the previous bump
2 · Reply
chwast94
chwast94 Jul. 9 at 6:44 PM
$SGMT zip_it_up how are your puts/shorts doing brother? You’ve been quiet since your meltdown
1 · Reply
John___wick44
John___wick44 Jul. 9 at 5:42 PM
$SGMT 38 BO
1 · Reply
Cheffar
Cheffar Jul. 9 at 4:07 PM
$SGMT In at $4.50 on 6/4, already doubled my money, holding for the $10 mark, baby needs new shoes.
1 · Reply
Rikilk
Rikilk Jul. 9 at 2:51 PM
$SGMT Let’s go for that $10
0 · Reply
Andryk
Andryk Jul. 9 at 2:51 PM
$SGMT i am In again! good looking chart
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Jul. 9 at 1:55 PM
$SGMT I love this stock and I'm attached. I know I'm breaking a cardinal sin.
1 · Reply
Bigggainzhere
Bigggainzhere Jul. 9 at 1:53 PM
$SGMT wow SagiAss has exceeded all expectations
0 · Reply
Norny44
Norny44 Jul. 9 at 12:17 PM
$SGMT $9.7 + today
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Jul. 9 at 12:14 AM
$SGMT I really like the consolidation and behavior on this!
0 · Reply